Biblio
“Classification of Depression, Cognitive Disorders, and Co-Morbid Depression and Cognitive Disorders with Perfusion SPECT Neuroimaging.”, J Alzheimers Dis, vol. 57, no. 1, pp. 253-266, 2017.
, “Perfusion Neuroimaging Abnormalities Alone Distinguish National Football League Players from a Healthy Population.”, J Alzheimers Dis, vol. 53, no. 1, pp. 237-41, 2016.
, “Inferring the Molecular Mechanisms of Noncoding Alzheimer's Disease-Associated Genetic Variants.”, J Alzheimers Dis, vol. 72, no. 1, pp. 301-318, 2019.
, “Mitochondria in Excitatory and Inhibitory Synapses have Similar Susceptibility to Amyloid-β Peptides Modeling Alzheimer's Disease.”, J Alzheimers Dis, vol. 60, no. 2, pp. 525-536, 2017.
, “The Effect of Escitalopram on Mood and Cognition in Depressive Alzheimer's Disease Subjects.”, J Alzheimers Dis, vol. 55, no. 2, pp. 727-735, 2017.
, “Orexin Impairs the Phagocytosis and Degradation of Amyloid-β Fibrils by Microglial Cells.”, J Alzheimers Dis, vol. 58, no. 1, pp. 253-261, 2017.
, “Discovery and Confirmation of Diagnostic Serum Lipid Biomarkers for Alzheimer's Disease Using Direct Infusion Mass Spectrometry.”, J Alzheimers Dis, vol. 59, no. 1, pp. 277-290, 2017.
, “Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 3, pp. 1109-1121, 2017.
, “A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1353-63, 2016.
, “The Relationship between Obstructive Sleep Apnea and Alzheimer's Disease.”, J Alzheimers Dis, vol. 64, no. s1, pp. S255-S270, 2018.
, “Validation by Magnetic Resonance Imaging of the Diagnostic Potential of a Heptapeptide-Functionalized Imaging Probe Targeted to Amyloid-β and Able to Cross the Blood-Brain Barrier.”, J Alzheimers Dis, vol. 60, no. 4, pp. 1547-1565, 2017.
, “Rhamnolipids, Microbial Virulence Factors, in Alzheimer's Disease.”, J Alzheimers Dis, vol. 59, no. 1, pp. 209-222, 2017.
, “Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-β Protein Precursor β in the Subcortical Small Vessel Type of Dementia.”, J Alzheimers Dis, 2023.
, “Diverging Progression of Network Disruption and Atrophy in Alzheimer's Disease and Semantic Dementia.”, J Alzheimers Dis, vol. 55, no. 3, pp. 981-993, 2017.
, “Late Onset Alzheimer's Disease Risk Variants in Cognitive Decline: The PATH Through Life Study.”, J Alzheimers Dis, vol. 57, no. 2, pp. 423-436, 2017.
, “Differentiating between Alzheimer's Disease and Vascular Cognitive Impairment: Is the "Memory Versus Executive Function" Contrast Still Relevant?”, J Alzheimers Dis, vol. 63, no. 2, pp. 625-633, 2018.
, “What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?”, J Alzheimers Dis, vol. 51, no. 3, pp. 793-800, 2016.
, “Clinical and Imaging Determinants of Neurocognitive Disorders in Post-Acute COVID-19 Patients with Cognitive Complaints.”, J Alzheimers Dis, vol. 87, no. 3, pp. 1239-1250, 2022.
, “Cognitive Impairment is Associated with Mortality in Hemodialysis Patients.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1529-1537, 2018.
, “Assessment of Driving Safety in Older Adults with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 57, no. 4, pp. 1197-1205, 2017.
, “Updating the Evidence on the Association between Serum Cholesterol and Risk of Late-Life Dementia: Review and Meta-Analysis.”, J Alzheimers Dis, vol. 56, no. 1, pp. 215-228, 2017.
, “Phospho-Tau Accumulation and Structural Alterations of the Golgi Apparatus of Cortical Pyramidal Neurons in the P301S Tauopathy Mouse Model.”, J Alzheimers Dis, vol. 60, no. 2, pp. 651-661, 2017.
, “Challenges in Screening and Recruitment for a Neuroimaging Study in Cognitively Impaired Geriatric Inpatients.”, J Alzheimers Dis, vol. 56, no. 1, pp. 197-204, 2017.
, “Association of Coffee Consumption with MRI Markers and Cognitive Function: A Population-Based Study.”, J Alzheimers Dis, vol. 53, no. 2, pp. 451-61, 2016.
, “A Novel Panel of Plasma Proteins Predicts Progression in Prodromal Alzheimer's Disease.”, J Alzheimers Dis, vol. 88, no. 2, pp. 549-561, 2022.
,